The Charcot-Marie-Tooth Association (CMTA) has announced a $90,860 investment in a groundbreaking two-year research project ...
CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF's Gladstone Institutes, targeting MFN2 mutations to restore nerve function. By investing in these MFN2 gene editing strategies ...